Robert M. Holster has served as one of our directors since May 2005 and as the Chairman of our Board of Directors since April 2006 (in a non-employee capacity since January 2011). From May 2005 to February 2009, Mr. Holster served as our Chief Executive Officer and from April 2001 to May 2005, he served as President and Chief Operating Officer. Previously, Mr. Holster served as our Executive Vice President from 1982 through 1993 and as one of our directors from 1989 through 1996. Mr. Holster previously served in a number of executive positions including Chief Executive Officer of HHL Financial Services, Inc., Chief Financial Officer of Macmillan, Inc. and Controller of Pfizer Laboratories, a division of Pfizer, Inc.

Holdings: 415,694 shares     View Transactions

Date	Type	Shares Traded	Price Range
Mar 14, 2013	Sell	20,000	30.92
Oct 5, 2012	Acquisition (Non Open Market)	5,366	27.79
Oct 5, 2012	Option Execute	45,000	8.00
Aug 3, 2012	Acquisition (Non Open Market)	45,000	8.00
Aug 3, 2012	Disposition (Non Open Market)	45,000	34.72
Mar 5, 2012	Disposition (Non Open Market)	100,000	n/a
Mar 5, 2012	Acquisition (Non Open Market)	100,000	n/a
Feb 22, 2012	Disposition (Non Open Market)	100,000	n/a
Feb 22, 2012	Acquisition (Non Open Market)	100,000	n/a
Oct 1, 2011	Acquisition (Non Open Market)	2,554	22.95
Sep 14, 2011	Sell	16,400	26.14
Aug 31, 2011	Sell	1,600	26.71
Aug 30, 2011	Sell	20,184	25.50 - 26.20
Aug 29, 2011	Sell	19,816	25.50
Aug 26, 2011	Sell	20,000	25.25
Aug 24, 2011	Sell	21,300	25.30
Mar 9, 2011	Sell	16,000	81.00
Mar 3, 2011	Sell	16,000	77.14
Mar 2, 2011	Sell	5,337	75.75
Mar 1, 2011	Sell	7,996	75.75
Feb 25, 2011	Option Execute	13,333	25.45
Jan 21, 2011	Option Execute	51,611	3.41
Dec 31, 2010	Acquisition (Non Open Market)	933	n/a
Nov 24, 2010	Sell	6,667	63.68
Nov 24, 2010	Option Execute	6,667	25.45
Nov 11, 2010	Sell	6,300	61.07
Nov 11, 2010	Sell	20,000	61.02
Nov 11, 2010	Option Execute	6,300	1.19
Nov 11, 2010	Option Execute	20,000	6.95
Nov 10, 2010	Sell	25,700	61.46
Nov 10, 2010	Option Execute	25,700	1.19
Sep 9, 2010	Sell	25,000	56.05
Sep 9, 2010	Option Execute	25,000	1.19
Sep 3, 2010	Sell	19,900	55.67
Sep 3, 2010	Option Execute	19,900	1.19
Sep 2, 2010	Sell	5,100	55.02
Sep 2, 2010	Option Execute	5,100	1.19
Aug 27, 2010	Sell	25,000	53.11
Aug 27, 2010	Option Execute	25,000	1.19
Aug 26, 2010	Sell	4,200	53.07
Aug 26, 2010	Option Execute	4,200	1.19
Aug 23, 2010	Sell	1,373	53.05
Aug 23, 2010	Option Execute	1,373	1.19
Aug 20, 2010	Option Execute	33,333	2.92
Aug 20, 2010	Sell	1,127	53.00
Aug 20, 2010	Option Execute	34,460	1.19 - 2.92
Aug 18, 2010	Sell	6,300	53.04
Aug 18, 2010	Option Execute	6,300	1.19
Aug 6, 2010	Option Execute	15,000	2.48
Aug 5, 2010	Sell	1,500	55.03

William C. Lucia has served as our President and Chief Executive Officer since March 2009 and as one of our directors since May 2008. From May 2005 to March 2009, Mr. Lucia served as our President and Chief Operating Officer. Since joining us in 1996, Mr. Lucia has held several positions with us, including: President of our subsidiary, Health Management Systems, Inc. from 2002 to 2009; President of our Payor Services Division from 2001 to 2002; Vice President and General Manager of our Payor Services Division from 2000 to 2001; Vice President of our Business Office Services from 1999 to 2000; Chief Operating Officer of our former subsidiary Quality Medical Adjudication, Incorporated (QMA) and Vice President of West Coast Operations from 1998 to 1999; Vice President and General Manager of QMA from 1997 to 1998; and Director of Information Systems for QMA from 1996 to 1997. Prior to joining us, Mr. Lucia served in various executive positions including Senior Vice President, Operations and Chief Information Officer for Celtic Life Insurance Company and Senior Vice President, Insurance Operations for North American Company for Life and Health Insurance. Mr. Lucia is a Fellow of the Life Management Institute (FLMI) Program through LOMA, an international association through which insurance and financial services companies around the world engage in research and educational activities to improve company operations.

Holdings: 305,426 shares     View Transactions

Date	Type	Shares Traded	Price Range
Apr 2, 2013	Automatic Sell	10,000	27.42
Apr 2, 2013	Option Execute	10,000	3.15
Feb 27, 2013	Acquisition (Non Open Market)	23,486	28.74
Feb 19, 2013	Disposition (Non Open Market)	10,376	27.27
Feb 18, 2013	Disposition (Non Open Market)	5,981	26.96
Nov 7, 2012	Option Execute	33,337	3.15
Oct 18, 2012	Automatic Sell	15,000	27.33
Oct 18, 2012	Option Execute	15,000	3.66
Sep 5, 2012	Automatic Sell	15,000	34.80
Sep 5, 2012	Option Execute	15,000	8.00
Aug 15, 2012	Automatic Sell	15,000	36.82
Aug 15, 2012	Option Execute	15,000	8.00
Jul 3, 2012	Automatic Sell	15,000	33.62
Jul 3, 2012	Option Execute	15,000	8.00
Jun 22, 2012	Automatic Sell	15,000	28.19
Jun 22, 2012	Option Execute	15,000	8.00
May 30, 2012	Automatic Sell	15,000	26.48
May 30, 2012	Option Execute	15,000	8.00
Apr 10, 2012	Automatic Sell	15,000	29.64
Apr 10, 2012	Option Execute	15,000	8.00
Mar 22, 2012	Automatic Sell	15,000	30.75
Mar 22, 2012	Option Execute	15,000	8.48
Feb 19, 2012	Disposition (Non Open Market)	10,160	33.06
Feb 16, 2012	Automatic Sell	15,000	33.28
Feb 16, 2012	Option Execute	15,000	8.48
Jan 5, 2012	Automatic Sell	15,000	30.70
Jan 5, 2012	Option Execute	15,000	8.48
Dec 15, 2011	Automatic Sell	15,000	30.47
Dec 15, 2011	Option Execute	15,000	8.48
Nov 10, 2011	Acquisition (Non Open Market)	20,000	3.15
Oct 31, 2011	Automatic Sell	15,000	23.31
Oct 31, 2011	Option Execute	15,000	3.15
Sep 27, 2011	Automatic Sell	15,000	25.41
Sep 27, 2011	Option Execute	15,000	2.32 - 3.15
Aug 11, 2011	Automatic Sell	5,000	65.08
Aug 11, 2011	Option Execute	5,000	6.95
Jul 20, 2011	Automatic Sell	5,000	75.92
Jul 20, 2011	Option Execute	5,000	6.95
Jun 14, 2011	Buy	1,000	72.80
Jun 2, 2011	Automatic Sell	5,000	76.49
Jun 2, 2011	Option Execute	5,000	6.95
May 19, 2011	Automatic Sell	5,000	77.33
May 19, 2011	Option Execute	5,000	6.95
Apr 5, 2011	Automatic Sell	5,000	83.30
Apr 5, 2011	Option Execute	5,000	6.95
Mar 16, 2011	Automatic Sell	5,000	78.05
Mar 16, 2011	Option Execute	5,000	6.95
Feb 18, 2011	Disposition (Non Open Market)	2,896	73.92
Feb 17, 2011	Acquisition (Non Open Market)	18,262	n/a
Feb 8, 2011	Automatic Sell	8,000	66.61

Daniel N. Mendelson has served as one of our directors since February 2013. Mr. Mendelson is the Chief Executive Officer of Avalere Health, a strategic advisory company which he founded in 2000. From 1998 - 2000, Mr. Mendelson served as Associate Director for Health at the White House Office of Management and Budget (OMB) in Washington, D.C.  Prior to joining OMB, Mr. Mendelson served as Senior Vice President and Director of the Medical Technology practice at The Lewin Group. Since 2000, Mr. Mendelson has also served as adjunct professor at Duke University’s Fuqua School of Business.  Mr. Mendelson serves as a director of Coventry Health Care Inc. and Champions Oncology.  From 2007 – 2011, Mr. Mendelson served as a director of PharMerica Corporation.

William F. Miller III has served as one of our directors since October 2000. Mr. Miller is a partner of Highlander Partners, a private equity group in Dallas, Texas focused on investments in healthcare products, services and technology. From October 2000 to April 2005, Mr. Miller served as our Chief Executive Officer and from December 2000 to April 2006, Mr. Miller served as our Chairman. From 1983 to 1999, Mr. Miller served as President and Chief Operating Officer of EmCare Holdings, Inc., a national healthcare services firm focused on the provision of emergency physician medical services. From 1980 to 1983, Mr. Miller served as Administrator/Chief Operating Officer of Vail Mountain Medical. Mr. Miller also serves as a director of Lincare Holdings, Inc. and several private companies.

Holdings: 150,454 shares     View Transactions

Date	Type	Shares Traded	Price Range
Mar 7, 2013	Sell	25,000	30.91
Oct 5, 2012	Acquisition (Non Open Market)	2,766	27.79
Aug 3, 2012	Acquisition (Non Open Market)	13,500	8.48
Aug 3, 2012	Disposition (Non Open Market)	13,500	34.47
Jun 1, 2012	Sell	30,000	26.50
Oct 1, 2011	Acquisition (Non Open Market)	2,554	22.95
Sep 14, 2011	Buy	10,000	25.45
Mar 8, 2011	Sell	6,650	80.50
Mar 8, 2011	Option Execute	6,650	14.66
Dec 31, 2010	Acquisition (Non Open Market)	933	n/a
Sep 8, 2010	Sell	33,299	55.54
Sep 7, 2010	Sell	6,701	55.05
Aug 18, 2010	Sell	9,491	53.00
May 13, 2010	Sell	6,107	56.53
May 8, 2010	Sell	40,000	52.15
Mar 5, 2010	Sell	900	46.50
Mar 3, 2010	Sell	100	46.50
Mar 2, 2010	Sell	11,000	46.50
Dec 3, 2009	Sell	25,000	45.21
Dec 3, 2009	Sell	25,000	45.21
Nov 9, 2009	Sell	25,000	43.91
Sep 14, 2009	Sell	50,000	38.16
Jun 2, 2009	Sell	25,000	37.14
May 12, 2009	Sell	25,000	37.00
Mar 13, 2009	Sell	25,000	35.25
Mar 3, 2009	Sell	50,000	30.86
Dec 8, 2008	Sell	50,000	30.17
Nov 20, 2008	Sell	50,000	26.36
Nov 5, 2008	Sell	3,357	25.75

William S. Mosakowski has served as one of our directors since December 2006. Mr. Mosakowski is the President and Chief Executive Officer of Public Consulting Group, Inc. (PCG), a management consulting firm which he founded in 1986. Prior to starting PCG, Mr. Mosakowski served as Assistant Revenue Director for the Massachusetts Department of Developmental Services (formerly the Department of Mental Health and Mental Retardation). He later served as Manager of Reimbursement for the Harvard Community Health Plan and was a senior consultant with Touche Ross & Company. Mr. Mosakowski is the Chairman of the Board of Trustees of Clark University and a founding benefactor of Clark University's Mosakowski Institute for Public Enterprise. Mr. Mosakowski serves on the Board of Directors of several private and not-for-profit companies.

Holdings: 46,619 shares     View Transactions

Date	Type	Shares Traded	Price Range
Oct 5, 2012	Acquisition (Non Open Market)	2,766	27.79
Aug 9, 2012	Acquisition (Non Open Market)	13,500	35.63
May 4, 2012	Acquisition (Non Open Market)	25,000	24.00
Oct 1, 2011	Acquisition (Non Open Market)	2,554	22.95
Dec 31, 2010	Acquisition (Non Open Market)	933	n/a
Dec 2, 2008	Sell	55,150	28.20
Dec 1, 2008	Sell	94,650	28.37
Nov 26, 2008	Sell	166,800	28.54
Nov 25, 2008	Sell	16,300	28.02
Nov 24, 2008	Sell	16,900	28.00

Ellen A. Rudnick has served as one of our directors since 1997. Since 1999, Ms. Rudnick has served as Executive Director and Clinical Professor of the Polsky Center for Entrepreneurship, University of Chicago Booth School of Business. From 1993 until 1999, Ms. Rudnick served as Chairman of Pacific Biometrics, Inc., a publicly held healthcare biodiagnostics company and its predecessor, Bioquant, which she co-founded. From 1990 to 1992, she served as President and Chief Executive Officer of Healthcare Knowledge Resources (HKR), a privately held healthcare information technology corporation and subsequently served as President of HCIA, Inc. (HCIA) following the acquisition of HKR by HCIA. From 1975 to 1990, Ms. Rudnick served in various positions at Baxter Health Care Corporation, including Corporate Vice President of Baxter Healthcare and President and Founder of Baxter Management Services Division. From 1992 to 2003, Ms. Rudnick served as Chairman of CEO Advisors, Inc., a privately held consulting firm. Ms. Rudnick also serves as a director of Patterson Companies, Inc. and First Midwest Bancorp, Inc.

Holdings: 17,119 shares     View Transactions

Date	Type	Shares Traded	Price Range
Mar 8, 2013	Sell	18,500	30.98
Mar 8, 2013	Option Execute	18,500	1.02
Oct 5, 2012	Acquisition (Non Open Market)	2,766	27.79
Aug 6, 2012	Acquisition (Non Open Market)	10,000	1.02
Aug 6, 2012	Disposition (Non Open Market)	10,000	34.85
Aug 3, 2012	Acquisition (Non Open Market)	10,000	1.02
Aug 3, 2012	Disposition (Non Open Market)	10,000	34.34
Aug 2, 2012	Acquisition (Non Open Market)	10,000	1.02
Aug 2, 2012	Disposition (Non Open Market)	10,000	34.01
Nov 11, 2011	Acquisition (Non Open Market)	25,000	1.02 - 8.48
Nov 11, 2011	Disposition (Non Open Market)	25,000	30.28
Oct 1, 2011	Acquisition (Non Open Market)	2,554	22.95
Feb 28, 2011	Acquisition (Non Open Market)	5,000	3.05
Feb 28, 2011	Disposition (Non Open Market)	5,000	75.50
Feb 25, 2011	Acquisition (Non Open Market)	5,000	3.05
Feb 25, 2011	Disposition (Non Open Market)	5,000	74.00
Dec 31, 2010	Acquisition (Non Open Market)	933	n/a
Nov 19, 2010	Sell	5,000	62.00
Nov 19, 2010	Option Execute	5,000	2.48
Nov 18, 2010	Sell	5,000	61.50
Nov 18, 2010	Option Execute	5,000	2.48
Nov 8, 2010	Sell	5,000	61.03
Nov 8, 2010	Option Execute	5,000	2.48
Nov 5, 2010	Sell	5,000	60.78
Nov 5, 2010	Option Execute	5,000	2.48
Nov 17, 2009	Sell	8,000	45.57 - 45.59
Nov 17, 2009	Option Execute	10,000	2.48
Mar 9, 2009	Sell	5,000	32.00
Mar 9, 2009	Option Execute	5,000	2.48
Mar 6, 2009	Sell	5,000	31.25
Mar 6, 2009	Option Execute	5,000	2.48
Mar 5, 2009	Sell	5,000	31.01
Mar 5, 2009	Option Execute	5,000	2.48
Feb 26, 2009	Sell	5,000	30.72
Feb 26, 2009	Option Execute	5,000	2.48
Dec 8, 2008	Sell	11,000	29.92
Dec 8, 2008	Option Execute	11,000	1.07 - 2.48

Bart M. Schwartz has served as one of our directors since July 2010. Mr. Schwartz currently serves as the Chairman and Chief Executive Officer of SolutionPoint International LLC which provides an integrated array of business intelligence, security and compliance, identity assurance and situational awarness solutions. In 2003, Mr. Schwartz founded his own law firm, which specializes in, among other areas, conducting independent investigations, monitoring and Independent Private Sector Inspector General engagements and developing, auditing and implementing compliance programs. From 1991 to 2003, Mr. Schwartz served as the Chief Executive Officer of Decision Strategies, an internationally recognized investigative and security firm, which was sold to SPX Corporation in 2001.

Holdings: 14,082 shares     View Transactions

Date	Type	Shares Traded	Price Range
Mar 22, 2013	Acquisition (Non Open Market)	288	28.19
Dec 28, 2012	Acquisition (Non Open Market)	219	25.57
Oct 5, 2012	Acquisition (Non Open Market)	2,766	27.79
Sep 28, 2012	Acquisition (Non Open Market)	168	33.39
Jul 2, 2012	Acquisition (Non Open Market)	168	33.31
May 21, 2012	Buy	1,500	24.62
Mar 23, 2012	Acquisition (Non Open Market)	179	31.33
Dec 30, 2011	Acquisition (Non Open Market)	175	31.98
Oct 1, 2011	Acquisition (Non Open Market)	2,554	22.95
Sep 23, 2011	Acquisition (Non Open Market)	230	24.42
Jun 24, 2011	Acquisition (Non Open Market)	77	73.42
May 4, 2011	Buy	750	76.36
Mar 25, 2011	Acquisition (Non Open Market)	69	81.54
Dec 31, 2010	Acquisition (Non Open Market)	1,019	0.00 - 64.77

Michael A. Stocker, M.D. has served as one of our directors since January 2007. Since September 2008, Dr. Stocker has served as Chairman of the Board of the New York City Health and Hospitals Corporation (HHC), the largest municipal hospital and health care system in the country. From January 2006 to April 2007, Dr. Stocker served as President and Chief Executive Officer of WellPoint, Inc.'s East Region. Dr. Stocker served as President and Chief Executive Officer of Empire Blue Cross Blue Shield from 1994 until its acquisition by Wellpoint, Inc. in December 2005. Dr. Stocker has also held executive level positions with both CIGNA and US Healthcare. Dr. Stocker serves as a director of Coventry Health Care, Inc. He also serves on the Boards of the Arthur Ashe Institute for Urban Health, New York Stem Cell Funding Committee, SeeChange Health and Triveris, Inc. (part of the Psilos Group).

Holdings: 8,119 shares     View Transactions

Date	Type	Shares Traded	Price Range
Oct 5, 2012	Acquisition (Non Open Market)	2,766	27.79
Aug 7, 2012	Acquisition (Non Open Market)	13,500	8.48
Aug 7, 2012	Disposition (Non Open Market)	13,500	35.10
Oct 1, 2011	Acquisition (Non Open Market)	2,554	22.95
Dec 31, 2010	Acquisition (Non Open Market)	933	n/a

Richard H. Stowe has served as one of our directors since 1989. Mr. Stowe is a general partner of Health Enterprise Partners LLP, a private equity firm. From 1999 to 2005, Mr. Stowe was a private investor, a senior advisor to the predecessor funds to Health Enterprise Partners and a senior advisor to Capital Counsel LLC, an asset management firm. From 1979 until 1998, Mr. Stowe was a general partner of Welsh, Carson, Anderson & Stowe. Prior to 1979, he was a Vice President in the venture capital and corporate finance groups of New Court Securities Corporation (now Rothschild, Inc.). Mr. Stowe is also a director of several private and not-for-profit companies and educational institutions. From 1998-2007, Mr. Stowe served as a director of MedQuist, Inc.

Holdings: 12,562 shares     View Transactions

Date	Type	Shares Traded	Price Range
Mar 22, 2013	Acquisition (Non Open Market)	576	28.19
Dec 28, 2012	Acquisition (Non Open Market)	439	25.57
Oct 5, 2012	Acquisition (Non Open Market)	2,766	27.79
Sep 28, 2012	Acquisition (Non Open Market)	336	33.39
Sep 10, 2012	Sell	60,000	33.76
Sep 10, 2012	Option Execute	60,000	1.02
Aug 1, 2012	Acquisition (Non Open Market)	13,500	8.48
Aug 1, 2012	Disposition (Non Open Market)	13,500	33.90
Jul 2, 2012	Acquisition (Non Open Market)	337	33.31
Mar 23, 2012	Acquisition (Non Open Market)	359	31.33
Dec 30, 2011	Acquisition (Non Open Market)	351	31.98
Oct 1, 2011	Acquisition (Non Open Market)	2,554	22.95
Sep 23, 2011	Acquisition (Non Open Market)	460	24.42
Jun 24, 2011	Acquisition (Non Open Market)	153	73.42
Mar 25, 2011	Acquisition (Non Open Market)	138	81.54
Dec 31, 2010	Acquisition (Non Open Market)	1,106	0.00 - 64.77
Dec 11, 2009	Sell	51,000	45.73
Dec 11, 2009	Option Execute	51,000	1.07

Cora M. Tellez has served as one of our directors since October 2012. Ms. Tellez is the President and Chief Executive Officer of Sterling HSA, an independent health savings accounts administrator which she founded in 2004. Prior to starting Sterling HSA, Ms. Tellez served as President of the health plans division of Health Net, Inc., an insurance provider. She later served as President of Prudential's western health care operations, CEO of Blue Shield of California, Bay Region and Regional Manager for Kaiser Permanente of Hawaii. Ms. Tellez serves on the Board of Directors of several private and not-for-profit companies.